Tropicamide

Chemical formula: C₁₇H₂₀N₂O₂  Molecular mass: 284.353 g/mol  PubChem compound: 5593

Therapeutic indications

Tropicamide is indicated for:

Ophthalmoscopy

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Tropicamide is a short acting anticholinergic agent used as a mydriatic and cycloplegic. It is indicated for topical use for:

Diagnostic purposes for fundoscopy and cycloplegic refraction.

Use in pre- and post-operative states where a short acting mydriatic is required.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Cycloplegic refraction

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Cycloplegic refraction

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tropicamide is contraindicated in the following cases:

Glaucoma

Glaucoma

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.